RSV vaccine boost in a new pregnancy
Treatments studied
Part of Infections clinical trials.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old and pregnant with one baby (no twins).
- You are 24 to 36 weeks into your pregnancy.
- You got the RSVpreF or Abrysvo vaccine during a previous pregnancy.
- You have had a normal ultrasound at 18 weeks or later in this pregnancy.
- You are not currently breastfeeding and have a pre-pregnancy BMI of 40 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody shot (called enflonsia) to help protect babies under 8 months old from RSV, a common virus that can cause breathing problems. If your baby qualifies, they will receive the shot and be followed for about 6 months to see how well it works.
This trial tests a booster dose of an experimental RSV vaccine (SCB-1019T) in healthy adults aged 60-85 who have already received the approved RSV vaccine AREXVY. The goal is to see if the booster is safe and boosts your immune system.
This study looks at how well RSV vaccines or antibody shots protect babies from severe respiratory infections. If your baby is under 1 year old, lives in Connecticut, and gets sick with a respiratory infection, they may be able to join.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
This study looks at how well the RSV vaccine given to pregnant women (called ABRYSVO) protects babies from getting RSV after birth. It uses national health data from Scotland to track health outcomes.
Hear when a new RSV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.